NVL_HUMAN - dbPTM
NVL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NVL_HUMAN
UniProt AC O15381
Protein Name Nuclear valosin-containing protein-like
Gene Name NVL
Organism Homo sapiens (Human).
Sequence Length 856
Subcellular Localization Isoform 2: Nucleus, nucleoplasm .
Isoform 1: Nucleus, nucleolus . Nucleus, nucleoplasm . Expressed predominantly in the nucleolus. Associates with pre-ribosomal particles in the nucleus.
Protein Description Participates in the assembly of the telomerase holoenzyme and effecting of telomerase activity via its interaction with TERT. [PubMed: 22226966 May play a role in 60S ribosomal subunit biogenesis]
Protein Sequence MKPRPAGFVDNKLKQRVIQYLTSNKCGKYVDIGVLASDLQRVYSIDYGRRKRNAFRIQVEKVFSIISSEKELKNLTELEDEHLAKRARQGEEDNEYTESYSDDDSSMEDYPDPQSANHMNSSLLSLYRKGNPDSVSNTPEMEQRETTSSTPRISSKTGSIPLKTPAKDSEGGWFIDKTPSVKKDSFFLDLSCEKSNPKKPITEIQDSKDSSLLESDMKRKGKLKNKGSKRKKEDLQEVDGEIEAVLQKKAKARGLEFQISNVKFEDVGGNDMTLKEVCKMLIHMRHPEVYHHLGVVPPRGVLLHGPPGCGKTLLAHAIAGELDLPILKVAAPEIVSGVSGESEQKLRELFEQAVSNAPCIIFIDEIDAITPKREVASKDMERRIVAQLLTCMDDLNNVAATARVLVIGATNRPDSLDPALRRAGRFDREICLGIPDEASRERILQTLCRKLRLPQAFDFCHLAHLTPGFVGADLMALCREAAMCAVNRVLMKLQEQQKKNPEMEDLPSKGVQEERLGTEPTSETQDELQRLLGLLRDQDPLSEEQMQGLCIELNDFIVALSSVQPSAKREGFVTVPNVTWADIGALEDIREELTMAILAPVRNPDQFKALGLVTPAGVLLAGPPGCGKTLLAKAVANESGLNFISVKGPELLNMYVGESERAVRQVFQRAKNSAPCVIFFDEVDALCPRRSDRETGASVRVVNQLLTEMDGLEARQQVFIMAATNRPDIIDPAILRPGRLDKTLFVGLPPPADRLAILKTITKNGTKPPLDADVNLEAIAGDLRCDCYTGADLSALVREASICALRQEMARQKSGNEKGELKVSHKHFEEAFKKVRSSISKKDQIMYERLQESLSR
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Sulfoxidation-------MKPRPAGF
-------CCCCCCCC
14.0531801345
12UbiquitinationPAGFVDNKLKQRVIQ
CCCCCCHHHHHHHHH
53.23-
15 (in isoform 2)Phosphorylation-56.14-
20PhosphorylationLKQRVIQYLTSNKCG
HHHHHHHHHHCCCCC
10.7920068231
22PhosphorylationQRVIQYLTSNKCGKY
HHHHHHHHCCCCCCE
25.8920068231
23PhosphorylationRVIQYLTSNKCGKYV
HHHHHHHCCCCCCEE
31.5320068231
25UbiquitinationIQYLTSNKCGKYVDI
HHHHHCCCCCCEEEE
44.10-
28AcetylationLTSNKCGKYVDIGVL
HHCCCCCCEEEEEEH
52.1226051181
28 (in isoform 2)Phosphorylation-52.12-
29PhosphorylationTSNKCGKYVDIGVLA
HCCCCCCEEEEEEHH
6.6622817900
32 (in isoform 2)Phosphorylation-2.68-
37PhosphorylationVDIGVLASDLQRVYS
EEEEEHHHHHHHHHH
34.3924719451
43PhosphorylationASDLQRVYSIDYGRR
HHHHHHHHHCCCCCC
11.3322817900
44PhosphorylationSDLQRVYSIDYGRRK
HHHHHHHHCCCCCCC
13.2121815630
47PhosphorylationQRVYSIDYGRRKRNA
HHHHHCCCCCCCCCE
15.7422817900
53 (in isoform 2)Phosphorylation-46.60-
64PhosphorylationIQVEKVFSIISSEKE
HHHHHHHHHHCCHHH
23.2329523821
67PhosphorylationEKVFSIISSEKELKN
HHHHHHHCCHHHHCC
30.6724505115
68PhosphorylationKVFSIISSEKELKNL
HHHHHHCCHHHHCCC
42.1329523821
70AcetylationFSIISSEKELKNLTE
HHHHCCHHHHCCCHH
71.0023749302
70UbiquitinationFSIISSEKELKNLTE
HHHHCCHHHHCCCHH
71.00-
73UbiquitinationISSEKELKNLTELED
HCCHHHHCCCHHHCH
51.51-
76PhosphorylationEKELKNLTELEDEHL
HHHHCCCHHHCHHHH
48.1728555341
79 (in isoform 2)Phosphorylation-55.94-
85AcetylationLEDEHLAKRARQGEE
HCHHHHHHHHHCCCC
53.6125953088
85UbiquitinationLEDEHLAKRARQGEE
HCHHHHHHHHHCCCC
53.61-
85 (in isoform 2)Phosphorylation-53.61-
89 (in isoform 2)Phosphorylation-63.77-
101PhosphorylationNEYTESYSDDDSSME
CCCCCCCCCCCCCCC
43.7919691289
101 (in isoform 2)Phosphorylation-43.79-
104 (in isoform 2)Phosphorylation-47.83-
105PhosphorylationESYSDDDSSMEDYPD
CCCCCCCCCCCCCCC
38.2819691289
105 (in isoform 2)Phosphorylation-38.28-
109 (in isoform 2)Phosphorylation-52.18-
110PhosphorylationDDSSMEDYPDPQSAN
CCCCCCCCCCHHHHC
9.0226307563
115PhosphorylationEDYPDPQSANHMNSS
CCCCCHHHHCCCCHH
36.1026307563
121PhosphorylationQSANHMNSSLLSLYR
HHHCCCCHHHHHHHH
18.1320068231
122PhosphorylationSANHMNSSLLSLYRK
HHCCCCHHHHHHHHH
28.4626307563
125PhosphorylationHMNSSLLSLYRKGNP
CCCHHHHHHHHHCCC
28.7526307563
127PhosphorylationNSSLLSLYRKGNPDS
CHHHHHHHHHCCCCC
13.6026307563
129AcetylationSLLSLYRKGNPDSVS
HHHHHHHHCCCCCCC
49.8619815419
129UbiquitinationSLLSLYRKGNPDSVS
HHHHHHHHCCCCCCC
49.86-
134PhosphorylationYRKGNPDSVSNTPEM
HHHCCCCCCCCCCHH
28.8025159151
136PhosphorylationKGNPDSVSNTPEMEQ
HCCCCCCCCCCHHHH
38.6521712546
138PhosphorylationNPDSVSNTPEMEQRE
CCCCCCCCCHHHHHH
17.0825159151
141SulfoxidationSVSNTPEMEQRETTS
CCCCCCHHHHHHCCC
5.8321406390
147PhosphorylationEMEQRETTSSTPRIS
HHHHHHCCCCCCCCC
18.87-
149PhosphorylationEQRETTSSTPRISSK
HHHHCCCCCCCCCCC
40.1025159151
150PhosphorylationQRETTSSTPRISSKT
HHHCCCCCCCCCCCC
19.1625159151
156AcetylationSTPRISSKTGSIPLK
CCCCCCCCCCCCCCC
50.5525953088
156UbiquitinationSTPRISSKTGSIPLK
CCCCCCCCCCCCCCC
50.55-
157PhosphorylationTPRISSKTGSIPLKT
CCCCCCCCCCCCCCC
37.8029396449
159PhosphorylationRISSKTGSIPLKTPA
CCCCCCCCCCCCCCC
26.6821815630
163UbiquitinationKTGSIPLKTPAKDSE
CCCCCCCCCCCCCCC
47.29-
164PhosphorylationTGSIPLKTPAKDSEG
CCCCCCCCCCCCCCC
35.8425159151
167AcetylationIPLKTPAKDSEGGWF
CCCCCCCCCCCCCEE
64.0926051181
167UbiquitinationIPLKTPAKDSEGGWF
CCCCCCCCCCCCCEE
64.09-
177AcetylationEGGWFIDKTPSVKKD
CCCEEECCCCCCCCC
58.4826051181
177UbiquitinationEGGWFIDKTPSVKKD
CCCEEECCCCCCCCC
58.48-
178PhosphorylationGGWFIDKTPSVKKDS
CCEEECCCCCCCCCC
19.6325159151
180PhosphorylationWFIDKTPSVKKDSFF
EEECCCCCCCCCCEE
52.3725159151
185PhosphorylationTPSVKKDSFFLDLSC
CCCCCCCCEEEEEEC
27.1225159151
191PhosphorylationDSFFLDLSCEKSNPK
CCEEEEEECCCCCCC
21.6425159151
192GlutathionylationSFFLDLSCEKSNPKK
CEEEEEECCCCCCCC
11.2522555962
194UbiquitinationFLDLSCEKSNPKKPI
EEEEECCCCCCCCCC
60.92-
195PhosphorylationLDLSCEKSNPKKPIT
EEEECCCCCCCCCCC
35.7520068231
199UbiquitinationCEKSNPKKPITEIQD
CCCCCCCCCCCCCCC
42.80-
202PhosphorylationSNPKKPITEIQDSKD
CCCCCCCCCCCCCCC
35.2530108239
207PhosphorylationPITEIQDSKDSSLLE
CCCCCCCCCCCCHHH
23.2225159151
208SumoylationITEIQDSKDSSLLES
CCCCCCCCCCCHHHH
70.67-
208SumoylationITEIQDSKDSSLLES
CCCCCCCCCCCHHHH
70.6728112733
210PhosphorylationEIQDSKDSSLLESDM
CCCCCCCCCHHHHHH
26.9925159151
211PhosphorylationIQDSKDSSLLESDMK
CCCCCCCCHHHHHHH
47.2925159151
215PhosphorylationKDSSLLESDMKRKGK
CCCCHHHHHHHHHCC
42.8726166824
249 (in isoform 2)Phosphorylation-42.00-
275AcetylationGGNDMTLKEVCKMLI
CCCCCCHHHHHHHHH
38.6526051181
290PhosphorylationHMRHPEVYHHLGVVP
HHCCHHHHHCCCCCC
5.05-
336PhosphorylationVAAPEIVSGVSGESE
HCCCHHHHCCCCCCH
38.8620860994
345UbiquitinationVSGESEQKLRELFEQ
CCCCCHHHHHHHHHH
45.52-
355PhosphorylationELFEQAVSNAPCIIF
HHHHHHHHCCCEEEE
30.2320058876
370PhosphorylationIDEIDAITPKREVAS
EEECCCCCCCHHHCC
25.2024719451
410PhosphorylationRVLVIGATNRPDSLD
EEEEEECCCCCCCCC
26.9220068231
492UbiquitinationAVNRVLMKLQEQQKK
HHHHHHHHHHHHHHH
42.74-
498AcetylationMKLQEQQKKNPEMED
HHHHHHHHHCCCHHH
54.9622361351
499UbiquitinationKLQEQQKKNPEMEDL
HHHHHHHHCCCHHHC
73.69-
508PhosphorylationPEMEDLPSKGVQEER
CCHHHCCCCCCCHHH
49.7124719451
509AcetylationEMEDLPSKGVQEERL
CHHHCCCCCCCHHHH
62.2526051181
509UbiquitinationEMEDLPSKGVQEERL
CHHHCCCCCCCHHHH
62.25-
562 (in isoform 3)Ubiquitination-26.1421890473
570UbiquitinationVQPSAKREGFVTVPN
CCCCCCCCCCEECCC
57.1721890473
626GlutathionylationLLAGPPGCGKTLLAK
EEECCCCCCHHHHHH
6.6122555962
628AcetylationAGPPGCGKTLLAKAV
ECCCCCCHHHHHHHH
39.8226051181
629PhosphorylationGPPGCGKTLLAKAVA
CCCCCCHHHHHHHHH
16.5822817900
633UbiquitinationCGKTLLAKAVANESG
CCHHHHHHHHHCCCC
43.28-
653 (in isoform 2)Ubiquitination-32.1521890473
655PhosphorylationGPELLNMYVGESERA
CHHHHHHHHCCHHHH
12.2920068231
668UbiquitinationRAVRQVFQRAKNSAP
HHHHHHHHHHHHCCC
45.6321890473
671UbiquitinationRQVFQRAKNSAPCVI
HHHHHHHHHCCCEEE
54.33-
695 (in isoform 2)Phosphorylation-38.65-
759UbiquitinationADRLAILKTITKNGT
HHHHHHHHHHHCCCC
31.5921890473
759 (in isoform 1)Ubiquitination-31.5921890473
794PhosphorylationCYTGADLSALVREAS
CCCCCCHHHHHHHHH
21.8020068231
801PhosphorylationSALVREASICALRQE
HHHHHHHHHHHHHHH
17.2820068231
814PhosphorylationQEMARQKSGNEKGEL
HHHHHHHCCCCCCCC
38.2121406692
826UbiquitinationGELKVSHKHFEEAFK
CCCCCCHHHHHHHHH
42.35-
833AcetylationKHFEEAFKKVRSSIS
HHHHHHHHHHHHHCC
58.3626051181
837PhosphorylationEAFKKVRSSISKKDQ
HHHHHHHHHCCHHHH
34.7026699800
838PhosphorylationAFKKVRSSISKKDQI
HHHHHHHHCCHHHHH
21.9526699800
840PhosphorylationKKVRSSISKKDQIMY
HHHHHHCCHHHHHHH
35.2821406692

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of NVL_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NVL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NVL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DPYL1_HUMANCRMP1physical
16169070
UBC9_HUMANUBE2Iphysical
21516116

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NVL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; THR-138; SER-185AND SER-191, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134; THR-138; SER-159;SER-207 AND SER-211, AND MASS SPECTROMETRY.

TOP